Notice 10 Apr 2025 energy, puerto rico, infrastructure, regulatory, environmental assessment, lng

🌊EcoEléctrica LNG Pipeline Project

The Federal Energy Regulatory Commission (FERC) has released an environmental assessment for EcoEléctrica L.P.'s proposed LNG Supply Pipeline Capacity Project in Puerto Rico. The project aims to double the existing gas supply capacity to meet increasing demand while assessing potential environmental effects in compliance with federal regulations. Public comments are invited to provide feedback on the assessment prior to final decisions.

Learn More
Notice 9 Apr 2025 regulatory, meeting, health, nih

🏥Amended Notice of Meeting for NIH Special Emphasis Panel

This document provides an amended notice regarding a meeting of the Center for Scientific Review Special Emphasis Panel, focusing on neurobehavior and neuropsychology topics. It details the meeting dates, location, and contact person change, specifying that the meeting is closed to the public.

Learn More
Notice 9 Apr 2025 policy, nih, regulatory, meeting notice, health

📅Notice of Closed Meeting Change at National Institute on Minority Health

The Department of Health and Human Services announces an amended notice regarding a meeting of the National Institute on Minority Health and Health Disparities. Originally scheduled for April, the meeting will now take place from June 23 to June 27, 2025. The meeting will be closed to the public and will focus on specific health disparities discussions by the Special Emphasis Panel.

Learn More
Notice 9 Apr 2025 fda, regulatory, drug approval, pharmaceutical, dexamethasone

💊FDA Confirms DECADRON Not Withdrawn for Safety or Effectiveness

The Food and Drug Administration (FDA, Agency, or we) has determined that DECADRON (dexamethasone sodium phosphate) solution/ drops, equivalent to (EQ) 0.1 percent phosphate, was not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to this drug product, and it will allow FDA to continue to approve ANDAs that refer to the product as long as they meet relevant legal and regulatory requirements.

Learn More
Notice 8 Apr 2025 business, federal energy regulatory commission, compliance, energy, filings, regulatory

⚡2025 Combined Notice of Filings by Federal Energy Regulatory Commission

The Federal Energy Regulatory Commission released a combined notice detailing various filings from electric corporations, including applications for mergers, tariff amendments, and rate filings. The notice outlines important comments dates and filing protocols, aiming to keep stakeholders informed of regulatory changes in the energy sector.

Learn More
Notice 4 Apr 2025 energy, regulatory, pennsylvania, infrastructure, hydropower, federal energy commission

⚡New England Hydropower Company Permit Application Notice

New England Hydropower Company, LLC has submitted a preliminary permit application for the Eastvale Dam Hydroelectric Project in Pennsylvania. This project aims to evaluate the feasibility of constructing a hydropower facility, which would contribute to energy generation while establishing priorities for future licensing applications. The notice invites public comments and competing applications.

Learn More
Notice 2 Apr 2025 compliance, regulatory, pharmaceuticals, california, dea, controlled substances

⚖️DEA Revokes Prescript Pharmaceuticals' Registration for Violations

The Drug Enforcement Administration issued an Order of Revocation against Prescript Pharmaceuticals after it violated federal regulations pertaining to the procurement of controlled substances. The order highlights the importance of compliance with the Controlled Substances Act, especially concerning the requirement for obtaining procurement quotas for manufacturing activities, and could set a precedent affecting other registrants.

Learn More
Notice 2 Apr 2025 public meeting, regulatory, fisheries, noaa, marine conservation, seafood

🦪Research Track Assessment Meeting for Atlantic Sea Scallops

NMFS will convene the Research Track Assessment Peer Review Meeting for the purpose of reviewing the Atlantic sea scallop stock. The Research Track Assessment Peer Review is a formal scientific peer- review process for evaluating and presenting stock assessment results to managers for fish stocks in the offshore U.S. waters of the northwest Atlantic. Assessments are prepared by the research track working group and reviewed by an independent panel of stock assessment experts from the Center of Independent Experts. The public is invited to attend the presentations and discussions between the review panel and the scientists who have participated in the stock assessment process.

Learn More
Notice 2 Apr 2025 compliance, nuclear, regulatory, radioactive materials, connecticut

⚛️NRC Proposes Agreement for Connecticut's Regulatory Authority Transfer

As required by section 274e. of the Atomic Energy Act of 1954, as amended (AEA), the U.S. Nuclear Regulatory Commission (NRC or Commission) is publishing the proposed Agreement for public comment (Appendix A). The NRC is also publishing the summary of a draft assessment by the NRC staff of the State of Connecticut's regulatory program. Comments are requested on the proposed Agreement and its effect on public health and safety. Comments are also requested on the draft staff assessment, the adequacy of the State of Connecticut's program, and the adequacy of the staffing of the State's program, as discussed in this document.

Learn More
Notice 2 Apr 2025 regulatory, business impact, real estate, historic preservation, national register

🏛️Comments on National Register of Historic Places Nominations

The National Park Service is soliciting electronic comments on the significance of properties nominated before March 22, 2025, for listing or related actions in the National Register of Historic Places.

Learn More